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The development of the DNA microarray, a novel tool assessing the
simultaneous expression profile of hundreds to thousands of genes,
has revolutionised molecular biology. Since 1995 and the first report
of the elaboration of a high-throughput system monitoring the expre-
ssion of many genes in only one experiment by Patrick O Brown, the
published papers based on this technology have proliferated.
In the past 6 years or so, microarray technology has been
extensively used to investigate numerous human tumour types and
other pathologies. Numerous publications reporting microarray-
generated results have significantly contributed to a better
understanding of the molecular events occurring in various
pathologies and have provided important insights into the true
pathobiologic nature of the diseases.
The present survey entitled ‘Gene expression profiling by
microarray – clinical implications’ provides nine chapters which
have been written by 26 contributors under the coordination of
Professor Wolf-Karsten Hofmann, who has been instrumental in
unraveling the pathobiology of leukaemia and lymphoma using
microarray technology. The stated purpose of this book is to serve
as a guide to help scientists better understand the overwhelming
number of publications reporting microarray-based studies. It is
well written, appropriately illustrated, easy to read and some
chapters are highly interesting, depending on the expertise and
focus of the reader. Each chapter provides an extensive overview of
the specific topic discussed and up-to-date references are used.
The first three chapters are particularly interesting, as they provide
a thorough review of the technology, concluded by a critical
analysis of the current advantages and drawbacks linked to
microarray analysis. In these sections, the authors evaluate the
different microarray platforms, probe labeling, image analysis,
various crucial and essential quality controls, etc.
Owing to the large amount of data generated by microarray
experiments, statistical analysis should be considered as the
cornerstone of such studies. Therefore, chapter 3, entitled,
‘Statistical analysis of gene expression data’ is the most important
one and should be dissected in each and every detail by an
investigator running this kind of assay. The review is clear and
accessible to a nonspecialised biostatistician.
Current diagnostics are not sufficient to accurately identify
discrete differences in tumours sharing the same origin or sharing
identical histopathological markers. As a result, treatments of
similar cancers diagnosed by conventional histopathological
criteria can have radically different outcomes. For this reason,
gene expression profiling can be exploited to improve not only the
accuracy of a diagnosis, but can also help to select the appropriate
treatment, which ultimately can lead to a more favourable
prognosis. The last six chapters cover the different kinds of
applications suggested above and made possible by microarray
technology. Indeed, the authors review some recent insights into
five diseases (heart failure and diabetes, together with breast
cancer, leukaemia and lymphoma) achieved by microarray gene
expression profiling. The last section provides a survey of the
recent studies focused on gene expression signatures and their
significance regarding the clinical outcome and the response to
specific drug regimens. This chapter discusses the outstanding
results obtained in non-Hodgkin’s lymphoma, acute lymphoblastic
leukaemia, breast cancer and in some other solid tumours, these
latter being briefly overviewed.
Although I have no major concerns about this book, one minor
problem is the lack of a final discussion that provides critical
evaluation and summarises the views of the panel of experts. This
leaves the reader a bit unsatisfied. Nevertheless, interesting future
perspectives are delineated throughout the different sections.
Haferlach and co-workers mentioned the beginning of a further
trial conducted by the European Leukaemia Network using 10 sites
and 4000 arrays to validate the microarray approach for diagnosis,
prognosis and treatment decisions. Although these kinds of
international trials can lead to the use of a standard microarray
platform, the introduction of the technology in routine clinical
application is still debated. Detection of gene expression alone
does not necessarily indicate that a protein is present. To provide
complete information, an interesting approach termed system
biology, encompassing analysis of an individual’s complete
biological system, has been suggested. Individualised therapy is
expected to emerge from this kind of study.
In conclusion, this is a well-written and informative book that
covers all the important aspects of the field. It is recommended to
readers who desire an overview of the field and to those who want
an overview of a specialised topic as well. I believe the authors have
reached their goal; this work will definitely help readers to make
sense of the large number of publications reporting DNA
microarray data.
J-P Gillet
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